Modulation of disease-associated gut microbiota by Schisandra chinensis: a literature review

Background: regulates the disease-related gut microbiota and to identify potential directions for future research. Methods: Relevant literature published between 2020 and 2025 was retrieved from Google scholar and NCBI PubMed. Two authors screened the literature based on titles and abstracts, followed by full-text screening by another two authors to ensure the inclusion of eligible studies. Results: alleviates the symptoms caused by ulcerative colitis, antibiotic-associated diarrhea, alcohol-associated liver disease, type 2 diabetes mellitus, Alzheimer's disease, non-alcoholic fatty liver disease, systemic inflammation, and neurobehavioral alterations associated with mental illness. Additionally, another study suggested that lignans influence bile acid production by modulating gut microbiota. Conclusion: in humans.